InvestorsHub Logo
icon url

prototype_101

01/05/23 6:09 AM

#563 RE: XenaLives #562

Xena, they manipulated this down to 14 cents or a 19 million market cap, every conference call the developments were meeting and exceeding expectations, the big problem was they have like 100 PhD's employed and the cash burn is huge and they got a delay from the biggest of the 17 customers they already have, Apple, but they have the Med side in addition to the Consumer side, so Medtronic is huge too, and margins are better on the Med side, bottom line Rkly has about 500 million invested capital, the original revenue forecast given in March 2022 was for 325 million in 2023 and 1.2 billion in 2024, so I'm guessing that there will be news today finally giving the updated revenue guidance, or perhaps it's a big funding deal, or lastly it's a cheap buyout offer at a buck or two by the M-team!
icon url

spartex

01/05/23 10:45 AM

#567 RE: XenaLives #562

Xena I was wondering about your other post (below) regarding Rockley and whether they may be working on something with Lightwave's polymers for their biosensors (Elec-Opitical), and possibly even with GFS. However, I know this isn't the immediate area of development that LWLG is working on very aggressively (modulators). Especially with some of Lightwave's recent hires (synthetic chemist, with focus on medical area).

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170866889